We are live on ! Find out more
BCM

Bourgeon Capital Management Portfolio holdings

AUM $679M
1-Year Est. Return 50.89%
This Fund
S&P 500
This Quarter Est. Return
+2.76%
1 Year Est. Return
+50.89%
3 Year Est. Return
+117.43%
5 Year Est. Return
+128.86%
10 Year Est. Return
+783.94%
AUM
$536M
AUM Growth
+$15.7M
Cap. Flow
+$15.8M
Cap. Flow %
2.95%
Top 10 Hldgs %
33.47%
Holding
130
New
25
Increased
35
Reduced
45
Closed
12

Top Sells

Rank Stock Value
1
OGN icon
Organon & Co
OGN
+$6.77M
2
GILD icon
Gilead Sciences
GILD
+$6.57M
3
DIS icon
Walt Disney
DIS
+$5.6M
4
APTV icon
Aptiv
APTV
+$4.77M
5
AMGN icon
Amgen
AMGN
+$4.22M

Sector Composition

Rank Sector Weight
1 Technology 20.93%
2 Healthcare 17.09%
3 Industrials 15.79%
4 Financials 13.49%
5 Energy 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOW icon
76
ServiceNow
NOW
$119B
$678K 0.13%
+3,200
New +$648K
IWD icon
77
iShares Russell 1000 Value ETF
IWD
$83.1B
$653K 0.12%
3,528
CPRT icon
78
Copart
CPRT
$26.6B
$628K 0.12%
+10,951
New +$624K
RIG icon
79
Transocean
RIG
$5.81B
$626K 0.12%
167,000
-4,500
-3% -$18.7K
SCHE icon
80
Schwab Emerging Markets Equity ETF
SCHE
$12.8B
$592K 0.11%
22,245
+579
+3% +$16.3K
CMG icon
81
Chipotle Mexican Grill
CMG
$42.4B
$569K 0.11%
+9,433
New +$569K
MSCI icon
82
MSCI
MSCI
$41.3B
$569K 0.11%
+948
New +$569K
MTD icon
83
Mettler-Toledo International
MTD
$28.3B
$562K 0.1%
459
IBB icon
84
iShares Biotechnology ETF
IBB
$9.48B
$558K 0.1%
4,218
+305
+8% +$42.9K
VRTX icon
85
Vertex Pharmaceuticals
VRTX
$123B
$546K 0.1%
+1,356
New +$629K
IWF icon
86
iShares Russell 1000 Growth ETF
IWF
$126B
$542K 0.1%
5,400
FXI icon
87
iShares China Large-Cap ETF
FXI
$4.27B
$541K 0.1%
17,761
+715
+4% +$22.5K
OIH icon
88
VanEck Oil Services ETF
OIH
$1.96B
$531K 0.1%
1,957
+83
+4% +$23.8K
DVYA icon
89
iShares Asia/Pacific Dividend ETF
DVYA
$71.6M
$504K 0.09%
14,089
+741
+6% +$27.7K
TTD icon
90
Trade Desk
TTD
$8.34B
$492K 0.09%
+4,187
New +$518K
EOG icon
91
EOG Resources
EOG
$71.5B
$489K 0.09%
3,989
+780
+24% +$99.7K
EMGF icon
92
iShares Emerging Markets Equity Factor ETF
EMGF
$1.86B
$475K 0.09%
10,510
+603
+6% +$29K
AMD icon
93
Advanced Micro Devices
AMD
$795B
$452K 0.08%
3,739
-8,998
-71% -$1.29M
SBUX icon
94
Starbucks
SBUX
$119B
$450K 0.08%
4,934
COST icon
95
Costco
COST
$420B
$435K 0.08%
475
+9
+2% +$8.35K
GRID
96
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund
GRID
$12B
$433K 0.08%
3,627
+239
+7% +$29.7K
BA icon
97
Boeing
BA
$185B
$423K 0.08%
+2,390
New +$375K
IGIB icon
98
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$411K 0.08%
7,974
+1,722
+28% +$90.2K
IWP icon
99
iShares Russell Mid-Cap Growth ETF
IWP
$20.3B
$399K 0.07%
3,151
IEFA icon
100
iShares Core MSCI EAFE ETF
IEFA
$194B
$369K 0.07%
5,251

Similar funds

Bourgeon Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Bourgeon Capital Management held 130 positions worth $536M, up 3% from $520M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Bourgeon Capital Management's Q4 2024 filing shows 25 new, 35 increased, 45 reduced and 12 closed positions. Its largest new stake was EQT Corp: 208,251 shares worth $9.6M. The largest sale was Organon & Co, an estimated $6.77M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

  • Bourgeon Capital Management's largest Q4 2024 buy was EQT Corp: 208,251 shares worth $9.6M.
  • Bourgeon Capital Management added most to Pfizer in Q4 2024, an estimated $9.76M increase.
  • Bourgeon Capital Management's biggest Q4 2024 reduction was Amgen, cutting an estimated $4.22M.
  • Bourgeon Capital Management fully exited Organon & Co in Q4 2024, selling an estimated $6.77M.
  • Bourgeon Capital Management's ten largest holdings make up 33% of its $536M portfolio in Q4 2024.
  • Bourgeon Capital Management opened 25 new positions and closed 12 in Q4 2024.
  • Bourgeon Capital Management's portfolio value rose 3% quarter-over-quarter to $536M.

Based on Bourgeon Capital Management's 13F filing for Q4 2024, filed 17 Jan 2025.